Serum Levels of Tartrate-Resistant Acid Phosphatase-5B in Breast Cancer Patients Treated with Pamidronate

乳腺癌 医学 酒石酸盐 内科学 酸性磷酸酶 癌症 乳腺 抗酒石酸酸性磷酸酶 癌症研究 肿瘤科 内分泌学 化学 生物化学 酶 破骨细胞 受体
作者
Antonia Martinetti,Ettore Cesare Seregni,Carla Ida Ripamonti,L. Ferrari,Franco De Conno,Rosalba Miceli,F. Pallotti,Angela Coliva,Donatella Biancolini,Emilio Bombardieri
出处
期刊:International Journal of Biological Markers [SAGE Publishing]
卷期号:17 (4): 253-258 被引量:22
标识
DOI:10.1177/172460080201700406
摘要

A novel immunoassay specific for the osteoclast-produced TRAP isoform 5b has been developed recently. By means of this assay we studied the usefulness of serum TRAP-5b in monitoring the response to palliative treatment with pamidronate in breast cancer patients with bone metastases. We correlated serum TRAP-5b levels with pain intensity and intake of analgesics to assess the possible utility of the marker in identifying patients who could benefit from pamidronate treatment. Twenty-eight advanced breast cancer patients with bone metastases entered the study. Patients were treated according to the following schedule: two two-week cycles of 60 mg/week pamidronate IV, with a three-week interval in between (six infusions over seven weeks), followed by one infusion every three weeks for a total of 24 infusions over a treatment period of 61 weeks. Blood samples were taken before the start of treatment and before each infusion during two treatment cycles. To measure serum TRAP levels we employed the new immunoassay kit BoneTRAP produced by Suomen Bioanalytiikka Oy (SBA), Oulu, Finland. In order to assess the usefulness of this marker in evaluating the response to pamidronate treatment we divided patients into two groups (group A, worsened; group B, improved) with respect to pain trend and analgesic intake. Our results did not show any statistically significant difference in baseline serum TRAP levels in the two groups. However, one week after the first pamidronate infusion TRAP-5b serum levels decreased by 39% and 18% in groups A and B, respectively (p=0.01); these levels persisted throughout the treatment period. In conclusion, a decrease in TRAP-5b serum levels may reflect the pharmacological activity of pamidronate and seems to predict pain relief and a reduction in analgesic consumption.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
企鹅完成签到,获得积分10
1秒前
田様的应助被xiahaijun采纳,获得10
3秒前
Ivan完成签到 ,获得积分10
3秒前
木南完成签到 ,获得积分10
3秒前
丘比特的应助被杨子墨采纳,获得10
5秒前
小王完成签到,获得积分10
6秒前
6秒前
vv完成签到 ,获得积分10
6秒前
悦耳代双完成签到 ,获得积分10
6秒前
陈凌雪完成签到,获得积分10
6秒前
纯牛奶完成签到 ,获得积分10
6秒前
zm18982426205完成签到 ,获得积分10
7秒前
Jimmychin完成签到,获得积分10
7秒前
8秒前
YOUNG-M完成签到,获得积分10
9秒前
lucaslucas完成签到 ,获得积分10
9秒前
delusionY完成签到 ,获得积分10
10秒前
Saber完成签到,获得积分10
10秒前
完美世界的应助被alandan采纳,获得10
10秒前
Cecilia完成签到,获得积分10
11秒前
尘有心完成签到 ,获得积分10
11秒前
爆米花的应助被liangchao采纳,获得50
11秒前
科研通AI6.2的应助被liangchao采纳,获得50
11秒前
科研通AI6.2的应助被liangchao采纳,获得50
11秒前
光亮向真发布了新的文献求助10
12秒前
15秒前
15秒前
15秒前
16秒前
姜糊完成签到 ,获得积分10
16秒前
yishu完成签到,获得积分20
17秒前
缺粥发布了新的文献求助10
18秒前
北冰洋的繇鱼完成签到,获得积分10
18秒前
yulihh完成签到,获得积分10
18秒前
18秒前
啊啊啊啊啊啊啊完成签到,获得积分10
19秒前
杨子墨发布了新的文献求助10
19秒前
Hh完成签到,获得积分10
20秒前
ffffwj2024完成签到,获得积分10
20秒前
研友_X89o6n完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190478
求助须知:如何正确求助?哪些是违规求助? 9577686
关于积分的说明 21853808
捐赠科研通 7789496
什么是DOI,文献DOI怎么找? 3436407
关于科研通互助平台的介绍 2560235
邀请新用户注册赠送积分活动 2483054